Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
about
Treatment of narcolepsy and other hypersomnias of central originPractice parameters for the treatment of narcolepsy and other hypersomnias of central originTreatment paradigms for cataplexy in narcolepsy: past, present, and futureA practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosisSodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysisPsychosis in patients with narcolepsy as an adverse effect of sodium oxybate.The use of sodium oxybate to treat narcolepsy.The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.Narcolepsy: current treatment options and future approachesTime to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsyTolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study.Sodium oxybate for cataplexy.Sodium oxybate for narcolepsy.Gamma-hydroxybutyrate--a drug of abuse.EFNS guidelines on management of narcolepsy.Armodafinil in the treatment of excessive sleepinessEvidence-based recommendations for the assessment and management of sleep disorders in older personsTreatment cost of narcolepsy with cataplexy in Central Europe.Evaluation of Quality of Life in Patients With Narcolepsy Treated With Sodium Oxybate: Use of the 36-Item Short-Form Health Survey in a Clinical Trial.Expert opinion on pharmacotherapy of narcolepsy.Nocturnal temazepam in the treatment of narcolepsy.Pharmacological management of narcolepsy and cataplexy in pediatric patients.Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy.Correlation of Changes in Patient-Reported Quality of Life With Physician-Rated Global Impression of Change in Patients With Narcolepsy Participating in a Clinical Trial of Sodium Oxybate: A Post Hoc Analysis.Challenges in the development of therapeutics for narcolepsy.Assessing narcolepsy with cataplexy in children and adolescents: development of a cataplexy diary and the ESS-CHAD.Diagnosis and management of central hypersomnias.Armodafinil in the treatment of excessive sleepiness.High mortality rates among GHB abusers in Western Sweden.Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice.Criteria for gauging response to sodium oxybate for narcolepsy.Effectiveness and side-effect profile of stimulant therapy as monotherapy and in combination in the central hypersomnias in clinical practice.Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls.Preface for the 3rd Clinical Update Sleep, 23rd February 2018, Royal College of Physicians, London, UK: year in review.
P2860
Q24648883-F3DFA51F-6EED-4A85-8660-5ED2537FCC74Q24648903-73D7149E-BF74-4613-A4B7-6EB6A644D05EQ26771634-B1C98C6E-4F61-46E4-99D9-BE898099D544Q26776231-42E45650-A694-48A4-BA6F-436D869F6BAEQ26865413-16F9E197-F3E5-4D67-A222-32A19B4E0C04Q34068000-395C6F07-C903-40D1-80BF-321A1A1625BFQ34272284-43218C5C-F0B0-4748-891C-79E0850269C8Q34458262-E30BE988-796B-4C3F-AEC7-4C3AC5FE8ABFQ34843237-D5F22A59-D064-4ED5-AFFC-64E700390A9FQ35193834-E3616F1E-166A-4315-BB3E-3BB6F4576161Q35875661-364D8F7A-ACDC-48DB-B8FC-9689C3E7BD83Q36409496-9FE58A42-CCA4-464C-A453-29646A63B99CQ36558659-51649271-7B32-4CEB-8478-A3454FC9236AQ36566720-C7E7A06F-CCAC-4BBA-BAE8-38F85A783456Q36598957-936F001A-8AF7-4FDB-9585-6F63FADDFD04Q36779799-EDB8250B-CB68-4080-B2EB-61313C04A51EQ37356250-C057408E-6D5C-4FD3-8B96-FD8D63A55269Q37446300-FAFC1A6E-8201-435B-8D84-03D7FE07BE58Q37459093-99F9D988-69A9-44AC-B652-863D051D7C8AQ37738902-68685367-231D-45E6-A673-1734EA9C85A5Q38106957-12FE61DB-98E3-4E86-B1FC-5AEB98AC325CQ38235204-6C79582B-AB8A-4FB8-928F-62383BEC6D3BQ38385249-BBBB84C0-0DFC-4C17-89DB-340C292CC9BBQ38679770-D2424769-1594-4FB1-BAAF-3A8AF0CE28EEQ38684472-B23A4ACE-F3CD-46B1-AEC3-31E60592A624Q41476656-FC1A8CF1-5239-4F24-9882-7396BF2AC4F6Q42161566-24054B8A-F585-4AAE-9CF7-A47235306AF6Q43122163-4896049A-4941-45F2-86C5-3A446A8631FCQ46699079-AFD4BA28-E29D-4398-91C4-7E1A2D858E34Q47102380-876813EF-8DF2-47B5-9D8B-3ABCB1770113Q47367845-3696F719-A024-436E-8663-0715CE1160C9Q47672150-5043231C-D3ED-4BE9-9A79-9E4C80EF0E14Q48275737-051A8926-7EE4-4AA0-B033-67E9EEF2F67AQ55191100-6DDAC284-96FC-4EDA-8EA4-987133DE91F4
P2860
Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Further evidence supporting th ...... trolled study in 228 patients.
@en
Further evidence supporting th ...... trolled study in 228 patients.
@nl
type
label
Further evidence supporting th ...... trolled study in 228 patients.
@en
Further evidence supporting th ...... trolled study in 228 patients.
@nl
prefLabel
Further evidence supporting th ...... trolled study in 228 patients.
@en
Further evidence supporting th ...... trolled study in 228 patients.
@nl
P1433
P1476
Further evidence supporting th ...... trolled study in 228 patients.
@en
P2093
Xyrem International Study Group
P304
P356
10.1016/J.SLEEP.2005.03.010
P577
2005-09-01T00:00:00Z